Suresh Nair - Researcher Profile | RDL Research Database

Publications

2 shown

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

Naiyer A. Rizvi , Julien Mazières , David Planchard +27 more

2015 The Lancet Oncology 1406 citations

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

Leora Horn , Martin Steins , Enriqueta Felip +26 more

Nivolumab was not associated with significantly longer progression-free survival than chemotherapy among patients with previously untreated stage IV or recurrent NSCLC with a PD...

2017 New England Journal of Medicine 2526 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 3,932
Institution: Lehigh Valley Hospital-Pocono

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-7763-9732

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.